AKT1 and breast carcinoma: Activation of PI3K/Akt and MAPK/Erk pathways have been demonstrated to be the link between O-GlcNAcylation and metastatic ability of various cancer cells, including thyroid anaplastic cancer [40] and breast cancer [41].